1. Home
  2. EMA vs ALGN Comparison

EMA vs ALGN Comparison

Compare EMA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EMA

Emera Incorporated Common Shares

HOLD

Current Price

$47.45

Market Cap

14.3B

Sector

Utilities

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMA
ALGN
Founded
1998
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
10.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EMA
ALGN
Price
$47.45
$157.47
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
$190.50
AVG Volume (30 Days)
190.9K
1.6M
Earning Date
11-07-2025
10-29-2025
Dividend Yield
4.38%
N/A
EPS Growth
67.89
N/A
EPS
2.65
5.16
Revenue
$6,126,111,896.00
$3,982,622,000.00
Revenue This Year
$24.94
$2.58
Revenue Next Year
N/A
$3.41
P/E Ratio
$18.04
$30.45
Revenue Growth
15.17
0.56
52 Week Low
$35.64
$122.00
52 Week High
$49.77
$246.19

Technical Indicators

Market Signals
Indicator
EMA
ALGN
Relative Strength Index (RSI) 43.14 73.38
Support Level $47.03 $144.00
Resistance Level $48.91 $152.99
Average True Range (ATR) 0.70 4.97
MACD -0.08 1.74
Stochastic Oscillator 19.15 92.40

Price Performance

Historical Comparison
EMA
ALGN

About EMA Emera Incorporated Common Shares

Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: